Qualimed Innovative Medizinproduke has received notice of CE mark approval for its line of peripheral balloons for the treatment of peripheral vascular obstructions.
Qualimed believes the availability of its current line of peripheral stents coupled with its line of PTA Balloons in .035, .018, and .014 guide wire compatibility up to 280mm lengths that minimise inflation and deflation time as well as a line of AV Shunt balloons in .035 and .018 guider compatibility with high pressure to 22 RBP, allows the company to provide one of the largest independent balloon production and product offerings globally. This balloon technology is available for sale through Qualimeds OEM, private label, and own branded sales channels.
The peripheral balloons, coupled with the company's currently approved line of peripheral vascular stents, aspiration devices will be launched in the 1st half of 2013. Qualimed believes that this will uniquely position it to take advantage of this channel opportunity and execute on its growth plans for in the Asia-Pacific and Middle East regions.
Eric Mangiardi, investor in Qualimed commented that they are very pleased to announce this significant milestone and to further execute the strategy to expand their product offering and technology advancements in the areas of interventional cardiology, peripheral vascular, and non-vascular areas. This new balloon technology will be the platform the company utilises to complete its illuminating balloon platform that allows visibility under x-ray without the use of contrast media and its entrance into the drug eluting balloon space.